• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anuh Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 2916.0
  • ISIN : INE489G01022
95.90 -1 (-1.16%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    95.10

  • Today’s High

    98.85

  • Open

    98.85

  • Perv Close

    97.03

  • 52W Low

    74.25

  • 52W High

    122.85

Key Indicators

  • P/E(TTM)

    23.16

  • Mar.Cap (₹Cr.)

    961.15

  • Div & Yield %

    0.78

  • Book Value(₹)

    32.53

  • Debt-Equity Ratio

    -1.16

  • AGM Date

    01-Aug-2025

  • EPS

    4.13

  • P/E Ratio

    23.16

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    961.15

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    50.11

  • BV (₹)

    32.50

  • Sales( ₹ in Cr.)

    661.51

  • NP (in Cr.)

    41.39

  • NP Var(%)

    -20.0

  • Div%

    30.0

  • CPS (₹)

    5.00

  • EPS (₹)

    4.10

  • Traded Value (₹ in Lakhs)

    958.74

  • 52 Week High

    122.85

  • 52 Week Low

    74.25

  • Price BSE

    96.0

  • Price NSE

    96.00

  • Market Capital( in Cr.)

    958.74

  • P/C Ratio

    19.20

  • P/E Ratio

    23.20

  • Price Vs.BV

    4.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 661.51 647.00 527.49 486.65 431.96 306.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 661.51 647.00 527.49 486.65 431.96 306.96
Other Income 9.46 12.10 6.11 5.20 10.54 4.21
Stock Adjustments 2.45 15.24 -13.48 4.86 -2.31 13.51
Total Income 673.42 674.34 520.12 496.71 440.19 324.68
EXPENDITURE :            
Raw Materials 501.82 501.90 388.00 382.54 327.49 243.67
Power and Fuel Cost 12.35 12.37 11.02 8.80 8.66 6.31
Employee Cost 23.04 19.39 17.15 15.10 14.29 13.36
Other Manufacturing Expenses 28.62 23.72 19.98 14.91 13.41 11.97
Selling and Administration Expenses 17.76 15.50 13.28 12.07 11.17 8.90
Miscellaneous Expenses 18.85 13.61 12.77 10.62 9.51 13.02
Employee Benefit Expenses 23.04 19.39 17.15 15.10 14.29 13.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 602.43 586.49 462.20 444.04 384.53 297.23
Operating Profit 70.98 87.85 57.92 52.66 55.66 27.45
Interest 1.24 0.96 0.75 1.58 2.03 1.26
Gross Profit 69.74 86.89 57.17 51.08 53.63 26.19
Depreciation 8.74 8.58 9.70 11.96 15.08 7.03
Profit Before Tax 61.00 78.31 47.47 39.12 38.55 19.16
Current Tax 14.67 18.13 12.12 10.58 9.47 3.54
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.02 0.12 -0.83 -2.02 0.65 1.31
Reported Net Profit 47.35 60.06 36.18 30.56 28.44 14.31
Extraordinary Items 5.96 8.17 3.24 1.97 5.94 1.06
Adjusted Net Profit 41.39 51.89 32.94 28.59 22.50 13.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 156.63 113.59 93.18 76.14 53.70 56.01
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 19.53 17.02 15.77 13.52 6.00 16.61
P & L Balance carried down 184.45 156.63 113.59 93.18 76.14 53.70
Dividend 0.00 0.00 0.00 0.00 0.00 6.89
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 50.00 40.00 35.00 30.00 55.00
Dividend Per Share(Rs) 1.50 2.50 2.00 1.75 1.50 2.75
Earnings Per Share-Unit Curr 9.45 11.98 7.22 6.10 5.67 5.71
Earnings Per Share(Adj)-Unit Curr 4.73 5.99 3.61 3.05 2.84 1.43
Book Value 65.06 58.11 48.14 42.66 38.04 64.74
Book Value(Adj)-Unit Curr 32.53 29.06 24.07 21.33 19.02 16.19

Shareholding Pattern

  • Promoter Group

    69.92%

  • Public Share Holding

    30.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 14,400 14,400.00 14,400 14,400
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 14,400 0.01 14,400 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 191,688 0.19 191,688 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 32,495,460 32.42 32,495,460 20
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,371,368 37.29 37,371,368 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 70,058,516 69.90 70,058,516 31
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 300 0.00 300 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26,134 0.03 26,134 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 26,434 0.03 26,434 2
2] Non Institution
Bodies Corporate 878,294 0.88 820,694 81
Clearing Members 35,330 0.04 35,330 11
Directors of their Relatives 12,906 0.01 12,906 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,997,366 1.99 1,997,366 430
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,199,110 1.20 1,199,110 521
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,761,336 8.74 8,430,136 75
Individuals holding nominal share capital up to Rs. 1 lakh 17,128,664 17.09 17,105,344 25,001
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 111,644 0.11 111,644 1
Sub Total 30,124,650 30.06 29,712,530 26,123
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 100,224,000 100.00 99,811,880 26,157

Company Background

Anuh Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Anuh Pharma Ltd
  • BSE Code : 2916.0
  • ISIN : INE489G01022

  • Incorporation Year

    1960

  • Registered Office

    3-A Shivsagar Estate
    North Wing Dr A B Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-6622 7575

  • FAX

    91-22-6622 7600

  • Chairman

    Arun L Todarwal

  • Managing Director

    Ritesh B Shah

  • Company Secretary

    Manan Jayesh Vadhan

  • Auditor

    Jayantilal Thakkar & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    BigShare Services Pvt Ltd
    J/12 Ansa Indl Est,
    Sakivihar Road,Sakinaka Andheri (E)
    Mumbai - Mumbai - 400072

Anuh Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anuh Pharma 95.66 670.97 661.51 20.27 17.15
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10